Metformin is more than an antidiabetic, it is also an anti-aging agent.
Learn how METFORMIN isn't just for prediabetes and type 2 diabetes. It has potential benefits against dementia, cancer, and anti-aging.
00:00 Introduction
00:40 Effects of low-grade inflammation
01:27 Study shows that people with type 2 diabetes who take metformin have better survival than diabetics who don't.
02:10 Trial shows the benefits of metformin on diseases associated with premature aging.
2:37 Study shows a 30% reduction in cancer incidence among those taking metformin to treat type 2 diabetes.
3:23 Study shows the benefits of metformin in reducing the incidence of dementia and cognitive decline among diabetics who took it.
4:28 What happens during insulin resistance.
5:40 By the time we diagnose prediabetes, the patient has had insulin resistance and excessive insulin levels in the blood for many years.
6:39 The negative effects of excessive insulin on the liver.
7:08 Fatty liver disease or hepatic steatosis in insulin resistance.
7:20 Excess insulin and high blood pressure, elevated LDL cholesterol and triglycerides, atherosclerosis, and cardiovascular risk for heart attack.
7:45 The negative effects of excess insulin on the brain.
8:15 Excess insulin and its relationship with cancer.
9:07 Zombie cells and insulin resistance.
9:40 How metformin reduces insulin resistance.
10:53 Effects of metformin in reducing chronic low-grade inflammation.
11:28 The antioxidant properties of metformin.